Skip to main content

Find Clinical Trials

Home
Conditions
Progressive Supranuclear Palsy

Clinical trial condition

Progressive Supranuclear Palsy

Explore clinical trials studying Progressive Supranuclear Palsy. Study availability and eligibility vary by location and protocol.

91 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Progressive Supranuclear Palsy trial results

Completed

A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy

NCT02422485

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: University of California, San Francisco San Francisco, California, United States

OHSU Parkinson Center & Movement Disorder Program Portland, Oregon, United States

View Trial Details

Completed

Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA)

NCT04786158

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Hôpital Fondation Adolphe de Rothschild Paris, Île-de-France Region, France

View Trial Details

Completed

Cognitive Impairement In Frontotemporal Dementia

NCT03452956

Conditions: Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +19 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

NCT02167594

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

UCSD Movement Disorder Clinic La Jolla, California, United States

UCSF Neurosciences Clinical Research Unit San Francisco, California, United States

Molecular Neuroimaging New Haven, Connecticut, United States

View Trial Details

Completed

Young Plasma Transfusions for Progressive Supranuclear Palsy

NCT02460731

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: University of California, San Francisco, Memory and Aging Center San Francisco, California, United States

View Trial Details

Completed

Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

NCT03545789

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +19 more
Locations: Invicro New Haven, Connecticut, United States

View Trial Details

Completed

tDCS Plus Physical Therapy for Progressive Supranuclear Palsy

NCT04237948

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Parkinson's disease Rehabilitation Centre - FERB ONLUS Trescore Balneario, Italy

View Trial Details

Completed

Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear Palsy

NCT04222218

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more
Locations: Parkinson's disease Rehabilitation Centre - FERB ONLUS Trescore Balneario, Italy

View Trial Details

Completed

Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy

NCT00328874

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: Neurologische Klinik der Philipps-Universität Marburg Marburg, Hesse, Germany

View Trial Details

Completed

18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls

NCT03625128

Conditions: Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +27 more
Locations: Chang Gung Memorial Hospital,Linkou Taoyuan City, Guishan Dist, Taiwan

View Trial Details